Cell and Gene Therapy Drug Delivery Devices Market Size, Share & Trends Analysis Report By Products (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-Filled Syringe, and Infusion Bags), Commercialized Drugs, Region, And Segment Forecasts, 2023-2031.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cell and Gene Therapy Drug Delivery Devices Market Snapshot

Chapter 4. Global Cell and Gene Therapy Drug Delivery Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Major Funding Investments in Cell and Gene Therapy Industry

4.8. COVID 19 Impact Analysis

Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis

5.1. By Products & Market Share, 2020 & 2030

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Products:

5.2.1. Subretinal Injection Cannula

5.2.2. Extension Tube

5.2.3. Intravenous Catheter

5.2.4. Sterile Insulin Syringe

5.2.5. Pre-Filled Syringe

5.2.6. Infusion Bags

Chapter 6. Cell and Gene Therapy Drug Delivery Devices Market Segmentation 2: By Commercialized Drugs Estimates & Trend Analysis

6.1. By Commercialized Drugs Analysis & Market Share, 2020 & 2030

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Commercialized Drugs:

6.2.1. Luxturna

6.2.2. Kymriah

6.2.3. Provenge

6.2.4. Zolgensma

6.2.5. Yescarta

6.2.6. Strimvelis

Chapter 7. Cell and Gene Therapy Drug Delivery Devices Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

7.1.2. North America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Commercialized Drugs, 2020-2030

7.1.3. North America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2030

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

7.2.2. Europe Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Commercialized Drugs, 2020-2030

7.2.3. Europe Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

7.3.2. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Commercialized Drugs, 2020-2030

7.3.3. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

7.4.2. Latin America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Commercialized Drugs, (US$ Million) 2020-2030

7.4.3. Latin America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA revenue Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

7.5.2. MEA revenue Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

7.5.3. MEA revenue Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Commercialized Drugs, (US$ Million) 2020-2030

7.5.4. MEA revenue Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

7.5.4.1. South Africa

7.5.4.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Amgen Inc.

8.2.2. Bausch & Lomb Incorporated.

8.2.3. Becton, Dickinson and Company

8.2.4. Bluebird bio, Inc.

8.2.5. Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)

8.2.6. Dendreon Pharmaceuticals LLC.

8.2.7. Helixmith Co., Ltd (ViroMed Co., Ltd)

8.2.8. Human Stem Cells Institute

8.2.9. Kite Pharma, Inc.

8.2.10. Kolon TissueGene, Inc.

8.2.11. Novartis AG

8.2.12. Orchard Therapeutics plc.

8.2.13. Pfizer, Inc.

8.2.14. Renova Therapeutics

8.2.15. Spark Therapeutics, Inc.

8.2.16. uniQure N.V.

8.2.17. Vericel Corporation

8.3. List of Other Prominent Players

Global Cell and Gene Therapy Drug Delivery Devices Market Segmentation

Global Cell and Gene Therapy Drug Delivery Devices Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2030 Based on Products

• Subretinal Injection Cannula
• Extension Tube
• Intravenous Catheter
• Sterile Insulin Syringe
• Pre-Filled Syringe
• Infusion Bags

Global Cell and Gene Therapy Drug Delivery Devices Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2030 Based on Commercialized Drugs

• Luxturna
• Kymriah
• Provenge
• Zolgensma
• Yescarta
• Strimvelis

Global Cell and Gene Therapy Drug Delivery Devices Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2030 Based on Region

• Europe
• North America
• Asia Pacific
• Latin America
• Middle East & Africa

Europe Cell and Gene Therapy Drug Delivery Devices Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019 to 2030

• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

North America Cell and Gene Therapy Drug Delivery Devices Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019 to 2030

• U.S.
• Canada

Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019 to 2030

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Cell and Gene Therapy Drug Delivery Devices Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019 to 2030

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019 to 2030

• GCC Countries
• South Africa
• Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

• Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
• External and internal proprietary databases, regulatory databases, and relevant patent analysis
• Statistical databases, National government documents, and market reports
• Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

• Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
• Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
• Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
• End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.